TMS denied for failing step therapy by Humana?

Humana's specific coverage criteria for tms are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana's Step-Therapy Requirement Is Blocking TMS — and How to Challenge It

A step-therapy denial means Humana requires evidence that you have tried and failed one or more prior treatment steps — typically a defined number of antidepressant medications, sometimes including augmentation strategies or psychotherapy — before it will authorize TMS. This is sometimes called a "fail-first" requirement. Humana's step-therapy criteria are spelled out in its published Medical Coverage Policy for TMS, and your appeal must demonstrate that your documented treatment history satisfies every required step.

Step-therapy denials are among the most frequently reversed on appeal, because patients who receive TMS referrals have almost always been through extensive prior treatment. The most common reason appeals fail is incomplete documentation: missing dates, gaps in the prescriber record, or inadequately documented reasons for stopping a prior medication.

## The Federal Appeal Framework

Under ACA §2719, non-grandfathered plans must provide internal appeal and independent external review. Many states have enacted additional step-therapy reform laws that give patients the right to an exception when the required steps are clinically contraindicated or have already been tried — check whether your state's law applies to your plan type. Under ERISA §503, self-funded employer plans must provide a full-and-fair review with written reasoning. An expedited appeal is available if your psychiatrist documents urgency. The external-review window is generally roughly four months after the internal denial; confirm the deadline in your denial letter.

## What to Gather

• Humana's current step-therapy criteria for TMS. Request the Medical Coverage Policy by name. List every required step. Your documentation must address each one.
• Complete prior medication history with dates. For each antidepressant trial: the medication name, start and end dates, dose range tried, reason for discontinuation (inadequate response, intolerance, contraindication), and prescribing clinician. Pharmacy records, discharge summaries, and visit notes are all useful sources.
• Prescriber medical-necessity letter. Your psychiatrist should confirm that the required steps have been tried, explain the outcomes, and state why TMS is now the appropriate next intervention.
• Diagnosis and severity documentation. Formal records establishing the diagnosis and current symptom severity.
• Step-therapy exception basis, if applicable. If any required medication was clinically contraindicated for you, or would have been harmful, your prescriber should document that specifically.

## Criteria-Mapping Structure

Create a table with one row per step in Humana's policy. For each: (1) state the requirement exactly as written; (2) identify the medication, dates, and outcome from your records; and (3) cite the document and page. Gaps invite denial. If a step was skipped for a documented clinical reason, explain it explicitly rather than leaving it blank.

## Next Step

File the internal appeal in writing before Humana's stated deadline. Attach the criteria-mapping table, the full medication history, and your prescriber's letter. If denied internally, immediately request external review in writing.